In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Excerpts from recent editorials in the United States and abroad: ___ Jan. 26 The Washington Post on Trump's “energy emergency” Oil and gas production in the United States is hitting record highs, ...

Minnesota Attorney General Keith Ellison says his office has settled with the last of the three largest insulin manufacturers ...

Minnesota Attorney General Keith Ellison announced on Monday that a settlement has been reached Novo Nordisk over the high ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Despite online claims, President Donald Trump’s executive orders did not include removing Medicare’s $35 monthly ...

according to the Health Care Cost Institute. The three major brand-name insulin manufacturers — Eli Lilly, Novo Nordisk and Sanofi — cut prices between 65% to 80% in 2024. Former Sen.

The three major brand-name insulin manufacturers — Eli Lilly, Novo Nordisk and Sanofi ... relief from the skyrocketing costs of medical care when they could have had it immediately ...

according to the Health Care Cost Institute. The three major brand-name insulin manufacturers — Eli Lilly, Novo Nordisk and Sanofi — cut prices between 65% to 80% in 2024. Former Sen. Richard Pan, a ...

Officials with Eli Lilly said the company has been working for years to reduce insulin out-of-pocket costs ... The high cost of health care has been at the forefront of national headlines ...